Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

44.15
+0.90122.08%
Post-market: 44.13-0.0156-0.04%19:30 EDT
Volume:5K
Turnover:233.98K
Market Cap:41.94M
PE:- -
High:44.42
Open:42.95
Low:42.95
Close:43.24
52wk High:56.18
52wk Low:28.35
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.30
T/O Rate:0.56%
Dividend:0.65
Dividend Rate:1.48%
ROE:--
ROA:--
PB:0.95
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
ARCA
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.